December 2022
Washington D.C. (Dec. 29, 2022)—Today, Oversight and Reform Committee Chairwoman Carolyn B. Maloney (D-NY) and Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) released a staff report following an 18-month investigation into the Food and Drug Administration's (FDA) regulatory review and approval process of Biogen's Alzheimer's disease drug Aduhelm, and Biogen's pricing of Aduhelm.
Chairwoman
Carolyn MaloneyNew York (12) |
Ranking Member
James ComerKentucky (01) |
Democratic Members
Eleanor NortonDistrict of Columbia (00) |
Stephen LynchMassachusetts (08) |
Jim CooperTennessee (05) |
Gerald ConnollyVirginia (11) |
Raja Krishnam |
Washington, D.C. (Dec. 23, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, released the following statement regarding the Committee's activity for the 117th Congress:
Washington, D.C. (Dec. 22, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, Rep. Jamie Raskin, Chairman of the Subcommittee on Civil Rights and Civil Liberties, and Rep.
Washington, D.C. (Dec. 22, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, released the following statement after Rep. Jamie Raskin (D-MD) was elected Ranking Member of the Committee on Oversight and Reform for the 118th Congress:
Washington D.C. (Dec. 20, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, released the following statement after the United States Postal Service announced a historic investment to electrify 75 percent of its fleet over the next five years and committed to purchasing only electric Next Generation Delivery Vehicles (NGDV) starting in 2026:
Washington, D.C. (Dec. 16, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Committee Member Rep.
Washington, D.C. (Dec. 15, 2022)—Today, Rep. Gerald E.
Washington, D.C. (Dec. 15, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep.